New study tracks how well darolutamide works for advanced prostate cancer in everyday practice
NCT ID NCT07344779
First seen Jan 16, 2026 · Last updated May 13, 2026 · Updated 18 times
Summary
This study looks at how well the drug darolutamide (combined with hormone therapy, and sometimes chemotherapy) works for men whose prostate cancer has spread and still responds to hormones. About 1,600 men from Europe will be followed during their normal treatment. The goal is to see how many reach very low PSA levels after one year and to track side effects and quality of life.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC HORMONE-SENSITIVE PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Many Locations
Multiple Locations, Belgium
-
Many Locations
Multiple Locations, Finland
-
Many Locations
Multiple Locations, France
-
Many Locations
Multiple Locations, Germany
-
Many Locations
Multiple Locations, Greece
-
Many Locations
Multiple Locations, Israel
-
Many Locations
Multiple Locations, Italy
-
Many Locations
Multiple Locations, Lithuania
-
Many Locations
Multiple Locations, Norway
-
Many Locations
Multiple Locations, Poland
-
Many Locations
Multiple Locations, Portugal
-
Many Locations
Multiple Locations, Saudi Arabia
-
Many Locations
Multiple Locations, Spain
-
Many Locations
Multiple Locations, Sweden
-
Many Locations
Multiple Locations, Switzerland
-
Many Locations
Multiple Locations, United Kingdom
Conditions
Explore the condition pages connected to this study.